Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 20;10(10):1761. doi: 10.3390/vaccines10101761

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Longitudinal analysis of T-lymphocytes throughout follow-up vaccination schedule. As of paired samples throughout vaccination scheme (pre-vaccine, first vaccine dose, and second vaccine dose) in COVID-19(−) and recovered COVID-19(+) participants, we analyzed (A) percentages of T-lymphocytes obtained from CD4 vs. CD3 plot, (B) percentages of follicular helper T-lymphocytes (TFH), obtained from CCR7 vs. CXCR5 plot gated on CD3+CD4+, and (C) percentages of memory T-lymphocytes obtained from CD45RA vs. CD45RO plot gated on CD3+CD4+. Central trend values and dispersion values are indicated in Table S11, Supplementary Data.